These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3278862)

  • 1. Development of diabetic nephropathy in the rat: morphological, functional, and pathophysiological aspects.
    Hasslacher C
    Contrib Nephrol; 1988; 60():9-17. PubMed ID: 3278862
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies of collagen metabolism in glomerular basement membrane in the pathogenesis of diabetic nephropathy].
    Satoh M
    Nihon Jinzo Gakkai Shi; 1988 Aug; 30(8):913-26. PubMed ID: 3244190
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunohistochemical localization of various components of the basal membrane and interstitial collagen in diabetic nephropathy].
    Nerlich A; Schleicher E
    Verh Dtsch Ges Pathol; 1989; 73():133-8. PubMed ID: 2482599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyantigenic expansion of basement membrane constituents in diabetic nephropathy.
    Falk RJ; Scheinman JI; Mauer SM; Michael AF
    Diabetes; 1983 May; 32 Suppl 2():34-9. PubMed ID: 6400667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycosaminoglycans prevent morphological renal alterations and albuminuria in diabetic rats.
    Gambaro G; Cavazzana AO; Luzi P; Piccoli A; Borsatti A; Crepaldi G; Marchi E; Venturini AP; Baggio B
    Kidney Int; 1992 Aug; 42(2):285-91. PubMed ID: 1328749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thiaproline reduces glomerular basement membrane thickness and collagen accumulation in the db/db mouse.
    Lubec B; Rokitansky A; Hayde M; Aufricht C; Wagner U; Mallinger WR; Höger H; Lubec G
    Nephron; 1994; 66(3):333-6. PubMed ID: 8190187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective proteinuria in diabetic nephropathy in the rat is associated with a relative decrease in glomerular basement membrane heparan sulphate.
    van den Born J; van Kraats AA; Bakker MA; Assmann KJ; van den Heuvel LP; Veerkamp JH; Berden JH
    Diabetologia; 1995 Feb; 38(2):161-72. PubMed ID: 7713310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes of glomerular basement membrane components in Vacor-induced diabetic nephropathy.
    Seon YD; Lee TH; Lee MC
    Korean J Intern Med; 1999 Jan; 14(1):77-84. PubMed ID: 10063318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Search for a biochemical basis of diabetic microangiopathy.
    Spiro RG
    Diabetologia; 1976 Mar; 12(1):1-14. PubMed ID: 767187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical alterations of the human glomerular basement membrane in diabetes.
    Westberg NG
    Diabetes; 1976; 25(2 SUPPL):920-4. PubMed ID: 971795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathobiochemical aspects of diabetic nephropathy.
    Schleicher E; Nerlich A; Gerbitz KD
    Klin Wochenschr; 1988 Sep; 66(18):873-82. PubMed ID: 2972877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation into the biochemical basis of diabetic basement-membrane alterations.
    Sprio RG
    Diabetes; 1976; 25(2 SUPPL):909-13. PubMed ID: 786762
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment with a glycosaminoglycan formulation ameliorates experimental diabetic nephropathy.
    Gambaro G; Venturini AP; Noonan DM; Fries W; Re G; Garbisa S; Milanesi C; Pesarini A; Borsatti A; Marchi E
    Kidney Int; 1994 Sep; 46(3):797-806. PubMed ID: 7527876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Serum laminin concentration in renal diseases].
    Horikoshi S; Funabiki K; Abe S; Koide H
    Nihon Jinzo Gakkai Shi; 1988 Jun; 30(6):745-8. PubMed ID: 3172570
    [No Abstract]   [Full Text] [Related]  

  • 15. [Biochemical and morphological changes in the glomerulus in diabetes mellitus].
    Westberg NG
    Lakartidningen; 1979 Aug; 76(35):2878-81. PubMed ID: 502651
    [No Abstract]   [Full Text] [Related]  

  • 16. The biochemical changes in early and advanced diabetic glomerulosclerosis are consistent.
    Westberg NG
    Acta Endocrinol Suppl (Copenh); 1981; 242():57-8. PubMed ID: 6940406
    [No Abstract]   [Full Text] [Related]  

  • 17. [Glycosaminoglycans in diabetic nephropathy].
    Olszowska A
    Pol Merkur Lekarski; 2000 Dec; 9(54):873-5. PubMed ID: 11255659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of heparan sulfate proteoglycan from glomerular basement membrane of nephrotic rats.
    Mynderse LA; Hassell JR; Kleinman HK; Martin GR; Martinez-Hernandez A
    Lab Invest; 1983 Mar; 48(3):292-302. PubMed ID: 6219248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of heparan sulphate-associated anionic sites in the glomerular basement membrane of rats with streptozotocin-induced diabetic nephropathy.
    van den Born J; van Kraats AA; Bakker MA; Assmann KJ; Dijkman HB; van der Laak JA; Berden JH
    Diabetologia; 1995 Oct; 38(10):1169-75. PubMed ID: 8690168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemistry of the basement membrane in diabetes mellitus.
    Brownlee M; Spiro RG
    Adv Exp Med Biol; 1979; 124():141-56. PubMed ID: 388998
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.